Wachstumsfaktoren in der Onkologie – richtiger Einsatz!

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

Ass. Dr. Angelika Bezan

Klinische Abteilung für Onkologie, Medizinische Universität Graz


AutorIn:
1 Preston NJ et al., Blood transfusions for anaemia in patients with advanced cancer. Cochrane Database Syst Rev 2012; 2:CD009007
2 Vansteenkiste J et al., Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy. J Natl Cancer Inst 2002; 94(16):1211–20
3 Chang J et al., Weekly epoetin alfa maintains hemo­globin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy. J Clin Oncol 2005; 23(12):2597–605
4 Tonia T et al., Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev 2012; 12:CD003407
5 Bennett CL et al., Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008; 299(8):914–24
6 Leyland-Jones B et al., Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 2005; 23(25):5960–72
7 Kumar A et al., Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34(6):1589–96
8 Kuderer NM et al., Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutro­penia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 2007; 25(21):3158–67
9 Lyman GH et al., Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review. J Clin Oncol 2010; 28(17):2914–24

UIM 09|2014

Herausgeber: o. Univ.-Prof. Dr. Günter J. Krejs, Österreichische Gesellschaft für Innere Medizin
Publikationsdatum: 2014-12-16